Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving more than one drug and giving the drugs in different ways
may kill more tumor cells.
PURPOSE: Randomized phase II trial to compare the effectiveness of three different regimens
of pemetrexed disodium plus gemcitabine in treating patients who have locally advanced or
metastatic non-small cell lung cancer.